• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Biocompatibility (2886)
Patient Problems Unspecified Infection (1930); Necrosis (1971); Reaction (2414)
Event Date 08/27/2019
Event Type  Injury  
Manufacturer Narrative
Image review: (physician notes and photo of leg): the physician notes describe two separate patient visits with led to the approval from treatment.The notes indicate symptomatic varicose veins have been identified.The notes did not specifically indicate the varicose veins would be treated using venaseal.Final physician note indicating ablation: "plan: varicose veins of right lower extremity with pain continue aspir-81, notes: right gsv reflux.Schedule ablation.The provided photo shows a leg with necrosis at the suspected access site and proximal from access site which was identified during post procedure follow up according to the customer.Redness around the identified areas of necrosis was identified.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Patient was treated with venaseal great saphenous vein (gsv) was treated.The vein is reported to have closed.Patient returned for follow-up appointment 5 days post implant and underwent a venous ultrasound which showed a dilated and refluxing left gsv.Patient continues to have left lower extremity aching, burning and cramping with varicosities despite conservative therapy including compression therapy, leg elevation and avoidance of prolonged sitting and standing over a period of 3 months with only partial relief reported.Patient cannot stand during the day without having to sit and elevate legs.It has been reported a reaction occurred post procedure resulting in necrosis at the access site and proximal from access site which was identified during post procedure follow up.Patient had been hospitalised for another condition.This resulted in partial explant of the cyanoacrylate at the access site and at the proximal from the access site.The patient is now reported to have open wounds at the mid and lower leg from the partial explant.Patient has been referred to a wound care centre for treatment.No further patient injuries reported.
 
Manufacturer Narrative
Additional information: necrosis at the access site was noticed by the physician a few days after the procedure.Access site was an open wound above the ankle.Physician note and image review: the physician notes describe two separate patient visits which led to the approval for treatment.The notes indicate symptomatic varicose veins have been identified.The provided photo shows a leg with necrosis at the suspected access site and proximal from access site which was identified during post procedure follow up according to the customer.Redness around the identified areas of necrosis was identified.Correction: patient age updated.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9590515
MDR Text Key175027103
Report Number9612164-2020-00236
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/02/2020
Initial Date FDA Received01/15/2020
Supplement Dates Manufacturer Received01/28/2020
02/14/2020
Supplement Dates FDA Received01/29/2020
02/20/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
Patient Weight57
-
-